KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Goodwill (2016 - 2026)

Evolent Health has reported Goodwill over the past 11 years, most recently at $694.5 million for Q4 2025.

  • For Q4 2025, Goodwill fell 38.94% year-over-year to $694.5 million; the TTM value through Dec 2025 reached $694.5 million, down 38.94%, while the annual FY2025 figure was $694.5 million, 38.94% down from the prior year.
  • Goodwill for Q4 2025 was $694.5 million at Evolent Health, down from $1.1 billion in the prior quarter.
  • Over five years, Goodwill peaked at $1.1 billion in Q3 2024 and troughed at $349.0 million in Q2 2021.
  • A 5-year average of $839.7 million and a median of $1.1 billion in 2024 define the central range for Goodwill.
  • Biggest five-year swings in Goodwill: surged 162.26% in 2023 and later plummeted 38.94% in 2025.
  • Year by year, Goodwill stood at $426.3 million in 2021, then skyrocketed by 69.55% to $722.8 million in 2022, then soared by 54.48% to $1.1 billion in 2023, then rose by 1.86% to $1.1 billion in 2024, then plummeted by 38.94% to $694.5 million in 2025.
  • Business Quant data shows Goodwill for EVH at $694.5 million in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.